- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06635486
Improving Mental Health in Forcibly Displaced Populations
Adaptation of an Open Source Cognitive Behavioral Treatment Protocol Designed to Improve Mental Health in Forcibly Displaced Populations
This project aims to improve mental health support for Venezuelan migrants living in Lima, Peru, who often face challenges like anxiety, depression, and post-traumatic stress disorder (PTSD). Since 2015, millions of Venezuelans have fled their country due to a severe humanitarian crisis, including extreme inflation, food shortages, and political unrest. Many of these individuals now live in Peru, where they struggle to access mental health services.
A new type of intervention that is both evidence-based and culturally adapted to meet the specific needs of Venezuelan migrants is the focus of this research. The intervention is designed to be delivered by trained lay providers-people from the community who have received special training but are not professional mental health workers. The intervention consists of 6 to 12 weekly online sessions, each lasting about an hour. These sessions will cover various therapeutic techniques, including cognitive restructuring (changing negative thought patterns), behavioral activation (encouraging positive activities), and emotional regulation (managing feelings). The sessions will be conducted remotely, allowing participants to join from the comfort of their homes.This approach is intended to make mental health care more accessible and relatable for migrants, who may feel more comfortable receiving help from someone who understands their cultural background and experiences.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
To assess the effectiveness of this intervention, 90 participants will be assigned into two groups: one that receives the intervention and another that will be on a waitlist for later participation. The investigators will measure changes in mental health symptoms using validated questionnaires throughout the study and at follow-up intervals. Participants will also provide feedback on their experience, providing information on how acceptable and feasible this approach is.
The three goals of the trial are:
- Efficacy: To determine if the intervention effectively reduces symptoms of anxiety, depression, and PTSD among participants.
- Feasibility and Acceptability: To evaluate how practical and well-received the intervention is by both participants and providers.
- Understanding Moderating Factors: To explore how individual experiences related to migration and integration affect the success of the intervention.
By focusing on a vulnerable population that often lacks access to traditional mental health resources, this project aims to provide valuable insights into effective mental health strategies for forcibly displaced individuals. If successful, the findings could help inform community leaders, non-governmental organizations (NGOs), and health care providers about how to better support Venezuelan migrants and potentially other migrant groups facing similar challenges in resource-limited settings.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Haley Carroll, PhD MS
- Phone Number: 617 414 2035
- Email: hcarrol1@bu.edu
Study Locations
-
-
-
Lima, Peru
- Recruiting
- Universidad del Pacifico
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
To be eligible to participate in this study, an individual must meet all of the following criteria:
- have Venezuelan nationality
- have arrived in Lima in years 2014 to the present
- be 18 years of age or older
In addition, in order to be eligible to participate in this study, an individual must meet one of the following criteria:
- score 10 points or more at the Patient Health Questionnaire (PHQ-9) or
- score 10 points or more at the General Anxiety Disorder (GAD-7) or
- have a history of trauma exposure as listed in the Life Events Checklist (LEC-5) and score 31 points or more in the PTSD Checklist (PCL-5)
Exclusion Criteria:
An individual is excluded from the study if they respond positively to one or more of the following questions during screening:
- Suicidal ideation: "When someone feels as upset as you do, they may have thoughts that life isn't worth living. What thoughts have you had like this?"
- Homicidal ideation: "When someone feels as upset as you do, they may have thoughts about hurting the person who has upset or hurt them. What thoughts have you had like this?"
- Psychosis: "Do you have a diagnosis of psychosis or schizophrenia?"
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention arm
Participants randomized to this arm will receive the CBT adapted intervention.
|
The intervention is 6-12 sessions, depending on the symptom presentation of the participant.
The weekly sessions last 60 minutes and will be delivered remotely and individually via Meet or a similar platform by trained lay providers.
Intervention methods include cognitive re-structuring, behavioral activation, exposure to memories and situations, problem solving, and emotional regulation.
Other Names:
|
|
No Intervention: Wait list control arm
Participants randomized to this arm will be placed on a wait list for the CBT adapted intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Anxiety
Time Frame: Throughout the study (on average 10 months for each participant). Outcome will be assessed every 2 weeks during the intervention (on average 3 months long), and after completion of the intervention at 1 month, 3 months, and 6 months follow-up
|
Anxiety will be assessed using the 7-item Generalized Anxiety Disorder (GAD-7).
Each item is scored from 0 to 3, where 0= Not at all and 3= Nearly every day, with a range of scores from 0 to 21.
The interpretation of scores are: 0 - 4: Minimal anxiety, 5 - 9: Mild anxiety, 10 -14: Moderate anxiety, and 15+: Severe anxiety.
|
Throughout the study (on average 10 months for each participant). Outcome will be assessed every 2 weeks during the intervention (on average 3 months long), and after completion of the intervention at 1 month, 3 months, and 6 months follow-up
|
|
Depression
Time Frame: Throughout the study (on average 10 months for each participant). Outcome will be assessed every 2 weeks during the intervention (on average 3 months long), and after completion of the intervention at 1 month, 3 months, and 6 months follow-up
|
Depression will be assessed using the 9-item Patient Health Questionnaire (PHQ-9).
Each item is scored from 0 to 3, where 0= Not at all and 3= Nearly every day, with a range of scores from 0 to 27.
The interpretation of scores are: 0-4: No or minimal depression, 5-9: Mild depression, 10-14: Moderate depression, 15-19: Moderately severe depression, 20-27: Severe depression.
|
Throughout the study (on average 10 months for each participant). Outcome will be assessed every 2 weeks during the intervention (on average 3 months long), and after completion of the intervention at 1 month, 3 months, and 6 months follow-up
|
|
Post Traumatic Stress Disorder (PTSD)
Time Frame: Throughout the study (on average 10 months for each participant). Outcome will be assessed every 1 week during the intervention (on average 3 months long), and after completion of the intervention at 1 month, 3 months, and 6 months follow-up
|
PTSD will be assessed with the PTSD Checklist (PCL-5).
Participants will rate how bothered they have been in the past month for 20 items where each is scored from 0 to 4, where 0=Not at all to 4=Extremely.
The range of scores is 0 to 80, and higher scores are associated with higher PTSD symptoms.
|
Throughout the study (on average 10 months for each participant). Outcome will be assessed every 1 week during the intervention (on average 3 months long), and after completion of the intervention at 1 month, 3 months, and 6 months follow-up
|
|
Traumatic Life Events
Time Frame: Throughout the study (on average 10 months for each participant). Outcome will be assessed every 2 weeks during the intervention (on average 3 months long), and after completion of the intervention at 1 month, 3 months, and 6 months follow-up
|
The Life Events Checklist for DSM-5 (LEC-5) will be used to assess traumatic life events.
It does not have a formal scoring protocol or interpretation, other than to identify if a person has experienced any of the listed events.
The LEC-5 does not provide a total or composite score.
|
Throughout the study (on average 10 months for each participant). Outcome will be assessed every 2 weeks during the intervention (on average 3 months long), and after completion of the intervention at 1 month, 3 months, and 6 months follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Recruitment feasibility
Time Frame: Throughout the study (on average 10 months for each participant). Outcome will be assessed for each participant one time at the start of the study.
|
Recruitment feasibility is defined as the percent of eligible participants who enroll in the study.
|
Throughout the study (on average 10 months for each participant). Outcome will be assessed for each participant one time at the start of the study.
|
|
Retention
Time Frame: Throughout the study (on average 10 months for each participant). Outcome will be assessed every 1 week during the intervention (on average 3 months long), and after completion of the intervention at 1 month, 3 months, and 6 months follow-up
|
Retention is defined as the number of participants who completed all study visits and follow-up assessments.
|
Throughout the study (on average 10 months for each participant). Outcome will be assessed every 1 week during the intervention (on average 3 months long), and after completion of the intervention at 1 month, 3 months, and 6 months follow-up
|
|
Fidelity
Time Frame: Throughout the intervention (on average 3 months for each participant). Outcome will be assessed every 1 week during the intervention.
|
Fidelity is defined by the adherence and competence scores (0 to 10) from research staff assessment of audio recorded sessions.
Higher scores are associated with greater fidelity.
|
Throughout the intervention (on average 3 months for each participant). Outcome will be assessed every 1 week during the intervention.
|
|
Provider perception of participant satisfaction
Time Frame: Throughout the intervention (on average 3 months for each participant). Outcome will be assessed every 1 week during the intervention.
|
Defined as the satisfaction of the participant in the session's helpfulness, enjoyment and relevance (0 to 10), with higher scores being associated with greater satisfaction.
|
Throughout the intervention (on average 3 months for each participant). Outcome will be assessed every 1 week during the intervention.
|
|
Provider perception of participants' future use
Time Frame: Throughout the intervention (on average 3 months for each participant). Outcome will be assessed every 1 week during the intervention.
|
Defined as participants' plans to use material learned in the future (Yes/No)
|
Throughout the intervention (on average 3 months for each participant). Outcome will be assessed every 1 week during the intervention.
|
|
Participant perception of participant satisfaction
Time Frame: Throughout the intervention (on average 3 months for each participant). Outcome will be assessed every 1 week during the intervention.
|
Defined as direct participant report of their satisfaction of the session's helpfulness, enjoyment and relevance (0 to 10), with higher scores being associated with greater satisfaction.
|
Throughout the intervention (on average 3 months for each participant). Outcome will be assessed every 1 week during the intervention.
|
|
Participant perception of future use
Time Frame: Throughout the intervention (on average 3 months for each participant). Outcome will be assessed every 1 week during the intervention.
|
Defined as participants' plans to use material learned in the future (Yes/No)
|
Throughout the intervention (on average 3 months for each participant). Outcome will be assessed every 1 week during the intervention.
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Haley Carroll, PhD MS, Boston Medical Center, BUCA School of Medicine
Publications and helpful links
General Publications
- Carroll HA, Guevara T, Gamarra P, Mukunta C, Dorsey S, Gelaye B, Henderson D, Bird MD, Frier LF. Protocol for a randomized pilot trial of COMPASS, an open source, culturally adapted cognitive behavioral therapy program for forcibly displaced Venezuelan adults in Peru. medRxiv [Preprint]. 2026 Mar 25:2026.03.19.26348265. doi: 10.64898/2026.03.19.26348265.
- Carroll HA, Guevara T, Gamarra P, Mukunta C, Dorsey S, Gelaye B, Henderson D, Bird MD, Freier LF. Protocol for a randomized pilot trial of COMPASS, an open-source, culturally adapted cognitive behavioral therapy program for forcibly displaced Venezuelan adults in Peru. PLoS One. 2026 Apr 24;21(4):e0345837. doi: 10.1371/journal.pone.0345837. eCollection 2026.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-45280
- 1K23MH127308 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
Clinical Trials on Adapted cognitive-behavioral (CBT) intervention
-
RANDNational Institute of Mental Health (NIMH)CompletedPost-Traumatic Stress DisorderUnited States
-
Koç UniversityCompletedDepressive Symptoms | Psychological Distress | Well-Being, PsychologicalTurkey (Türkiye)
-
Children's National Research InstitutePatient-Centered Outcomes Research Institute; George Washington UniversityActive, not recruitingPerinatal Depression | Prenatal Stress | Perinatal AnxietyUnited States
-
University of California, Los AngelesNational Institute of Nursing Research (NINR)Completed
-
University of WashingtonNational Institute of Mental Health (NIMH)RecruitingTrauma and Stressor Related Disorders | Trauma, PsychologicalUnited States
-
Koç UniversityCompletedPsychological Distress | Well-beingTurkey
-
Wenzhou Medical UniversityWuhan University; Second Affiliated Hospital, School of Medicine, Zhejiang... and other collaboratorsCompletedDepression | Breast Cancer | AnxietyChina
-
Amy Farabaugh, PhDBeth Israel Deaconess Medical Center; Brigham and Women's HospitalUnknownParkinson's Disease | Major Depressive DisorderUnited States
-
Khyber Medical University PeshawarKeele University; Hayatabad Medical ComplexRecruitingDepression | HIV Infections | Anxiety DisordersPakistan
-
Claremont McKenna CollegeUniversity of California, Los AngelesCompleted